Jazz Pharmaceuticals
JAZZ
#2156
Rank
NZ$12.28 B
Marketcap
$203.20
Share price
2.07%
Change (1 day)
1.72%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): NZ$0.48 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$3.90 Billion. In 2023 the company made an earning of NZ$0.50 Billion, an increase over its 2022 earnings that were of -NZ$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.48 B-4.07%
2023 NZ$0.50 B-179.92%
2022 -NZ$0.64 Billion230.37%
2021 -NZ$0.2 Billion-141.02%
2020 NZ$0.46 B-39.45%
2019 NZ$0.77 B-14.2%
2018 NZ$0.90 B20.03%
2017 NZ$0.75 B-17.15%
2016 NZ$0.90 B22.14%
2015 NZ$0.74 B187.64%
2014 NZ$0.25 B-50.79%
2013 NZ$0.52 B73.63%
2012 NZ$0.30 B41.69%
2011 NZ$0.21 B116.61%
2010 NZ$98.47 M262.77%
2009 NZ$27.14 M-111.33%
2008 -NZ$0.24 Billion1.31%
2007 -NZ$0.24 Billion77.8%
2006 -NZ$0.14 Billion36.59%
2005 -NZ$97.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$4.08 Billion-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.57 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.69 B 4,181.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$1.40 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel